Preferred Label : finasteride;

MeSH definition : An orally active 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE inhibitor. It is used as a surgical alternative for treatment of benign PROSTATIC HYPERPLASIA.;

CISMeF synonym : frosst iberica brand of finasteride; MSD chibropharm brand of finasteride; merck frosst brand 2 of finasteride; merck sharp & dhome brand 2 of finasteride; cahill may roberts brand of finasteride; merck brand 2 of finasteride; MSD brand of finasteride; merck frosst brand 1 of finasteride; lipha brand of finasteride; merck brand 1 of finasteride; merck sharp & dohme brand 1 of finasteride;

MeSH hyponym : proscar; eucoprost; MK-906; propecia; Chibro-Proscar; Chibro Proscar; Propeshia; MK 906; MK906;

MeSH CAS label : 4-Azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5alpha,17beta)-;

MeSH Related Number : 98319-26-7 (Finasteride);

Registry Number MeSH : 98319-26-7;

Wikipedia link : https://en.wikipedia.org/wiki/Finasteride;

Is substance : O;

UNII : 57GNO57U7G;

InChIKey : DBEPLOCGEIEOCV-WSBQPABSSA-N;

Details


Main resources

You can consult :

An orally active 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE inhibitor. It is used as a surgical alternative for treatment of benign PROSTATIC HYPERPLASIA.

https://ansm.sante.fr/actualites/reevaluation-europeenne-de-la-balance-benefice-risque-des-medicaments-contenant-du-finasteride-ou-du-dutasteride
2024
false
false
false
France
French
drug information
finasteride
Dutasteride
product surveillance, postmarketing
pharmacovigilance

---
https://ansm.sante.fr/actualites/finasteride-1-mg-propecia-et-generiques-ajout-de-mentions-dalerte-sur-les-boites-pour-renforcer-linformation-sur-les-effets-indesirables
2022
false
false
false
France
French
drug information
finasteride
finasteride
patient education handout
alopecia
administration, oral
mental disorders
Reduced libido (finding)
erectile dysfunction
Testicular Pain
Ejaculation Disorder

---
https://ansm.sante.fr/dossiers-thematiques/finasteride-1-mg-et-chute-de-cheveux
2022
false
false
false
France
French
continuity of patient care
alopecia
patients guideline
guideline
drug information
finasteride
finasteride
administration, oral
finasteride
androgenetic alopecia

---
https://www.ansm.sante.fr/actualites/lansm-renforce-linformation-sur-le-finasteride-1-mg-utilise-contre-la-chute-de-cheveux
2019
false
false
false
France
French
androgenetic alopecia
finasteride
finasteride
finasteride
patients guideline
drug information
alopecia

---
http://www.lecrat.eu/?s=Finast%C3%A9ride+-+exposition+paternelle
2019
false
false
false
France
French
scientific and technical information
paternal exposure
finasteride

---
http://www.has-sante.fr/portail/jcms/c_2752853/fr/chibro-proscar
2017
false
false
false
France
French
evaluation of the transparency committee
finasteride
treatment outcome
insurance, health, reimbursement

---
http://www.has-sante.fr/portail/jcms/c_2583323/fr/finasteride-arrow-lab
2015
false
France
French
drugs, generic
evaluation of the transparency committee
finasteride
administration, oral
prostatic hyperplasia
finasteride
5-alpha reductase inhibitors
insurance, health, reimbursement
urinary retention
prostatic hyperplasia
treatment outcome

---
Finasteride and suicidality
https://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/hpiw-ivps_2015-12-fra.php#a4.1
2015
false
false
false
Canada
French
English
finasteride
finasteride
5-alpha reductase inhibitors
suicidal ideation
self-injurious behavior
benign prostatic hyperplasia
finasteride
androgenetic alopecia
pharmacovigilance note
journal article
prostatic hyperplasia
alopecia

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62828991
2012
France
summary of product characteristics
package leaflet
tablets
finasteride

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69153913
2012
France
summary of product characteristics
package leaflet
finasteride
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62517392
2012
France
summary of product characteristics
package leaflet
tablets
finasteride

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60189609
2012
France
summary of product characteristics
package leaflet
tablets
finasteride

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67145743
2012
France
summary of product characteristics
package leaflet
finasteride
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68401423
2012
France
summary of product characteristics
package leaflet
finasteride
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60658750
2012
France
summary of product characteristics
package leaflet
tablets
finasteride

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66713965
2012
France
summary of product characteristics
package leaflet
tablets
finasteride

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62489815
2012
France
summary of product characteristics
package leaflet
finasteride
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66666939
2012
France
summary of product characteristics
package leaflet
tablets
finasteride

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62316507
2012
France
summary of product characteristics
package leaflet
finasteride
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69699613
2012
France
summary of product characteristics
package leaflet
finasteride
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63127452
2012
France
summary of product characteristics
package leaflet
finasteride
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63560165
2012
France
summary of product characteristics
package leaflet
finasteride
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67836928
2012
France
summary of product characteristics
package leaflet
tablets
finasteride

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60221042
2012
France
summary of product characteristics
package leaflet
finasteride
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66921845
2012
France
summary of product characteristics
package leaflet
finasteride
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69693507
2012
France
summary of product characteristics
package leaflet
finasteride
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61897600
2012
France
summary of product characteristics
package leaflet
tablets
finasteride

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69428925
2012
France
summary of product characteristics
package leaflet
finasteride
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60123363
2012
France
summary of product characteristics
package leaflet
tablets
finasteride

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62690191
2012
France
summary of product characteristics
package leaflet
tablets
finasteride

---
http://www.has-sante.fr/portail/jcms/c_1353463/avodart-dutasteride-chibro-proscar-finasteride-combodart-dutasteride-tamsulosine
http://www.has-sante.fr/portail/jcms/c_1353462/avodart-chibro-proscar-combodart-synthese-ct9291-9896-11612-12202
2012
false
France
French
Dutasteride
Dutasteride
administration, oral
insurance, health, reimbursement
dutasteride
tamsulosin and dutasteride
drug combinations
finasteride
finasteride
prostatic hyperplasia
finasteride
5-alpha reductase inhibitors
5-alpha reductase inhibitors
guidelines for drug use
sulfonamides
Tamsulosin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61672151
2012
France
summary of product characteristics
package leaflet
finasteride
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67685458
2012
France
summary of product characteristics
package leaflet
tablets
finasteride

---
http://www.cochrane.org/fr/CD006015
2012
United Kingdom
France
French
meta-analysis
finasteride
prostatic hyperplasia
treatment outcome
5-alpha reductase inhibitors
prostatism
french abstract

---
https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2012/13665a-fra.php
2012
false
Canada
French
English
Dutasteride
sulfonamides
risk
administration, oral
prostatic neoplasms
finasteride
5-alpha reductase inhibitors
finasteride
finasteride
dutasteride
tamsulosin and dutasteride
drug combinations
prostatic hyperplasia
alopecia
androgenetic alopecia
pharmacovigilance note
Tamsulosin

---
http://www.has-sante.fr/portail/jcms/c_399217/chibro-proscar-5-mg-comprime-pellicule-boite-de-28-comprimes
http://www.has-sante.fr/portail/jcms/c_1058681/chibro-proscar
http://www.has-sante.fr/portail/jcms/c_1313141/chibro-proscar
http://www.has-sante.fr/portail/jcms/c_539638/chibro-proscar
http://www.has-sante.fr/portail/jcms/c_555406/chibro-proscar
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-10/chibro-proscar_05092012_ct_11612.pdf
2012
France
French
evaluation of the transparency committee
finasteride
administration, oral
prostatic hyperplasia
finasteride
5-alpha reductase inhibitors
finasteride
5-alpha reductase inhibitors
risk assessment
product surveillance, postmarketing
breast neoplasms, male
insurance, health, reimbursement
urinary retention
prostatic hyperplasia
prostatic hyperplasia
risk management
prostatic neoplasms
treatment outcome

---
https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2011/13530a-fra.php
2011
Canada
French
English
pharmacovigilance note
finasteride
risk
finasteride
finasteride
breast neoplasms, male
5-alpha reductase inhibitors
prostatic hyperplasia
alopecia
administration, oral

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64993924
2009
France
French
finasteride
summary of product characteristics
package leaflet

---
http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F36F04G
2009
Belgium
French
Dutch
finasteride
enzyme inhibitors
3-Oxo-5-alpha-Steroid 4-Dehydrogenase
alopecia
finasteride
5-alpha reductase inhibitors
drug information

---
http://revmed.ch/RMS/2005/RMS-2/30050
2005
true
Switzerland
French
prostatic hyperplasia
doxazosin
antihypertensive agents
finasteride
drug therapy, combination
journal article

---
https://minerva-ebp.be/fr/article/849
2004
false
false
minerva-ebm.be
Belgium
French
prostatic hyperplasia
doxazosin
finasteride
enzyme inhibitors
drug therapy, combination
treatment outcome
disease progression
enzyme inhibitors
doxazosin
finasteride
3-Oxo-5-alpha-Steroid 4-Dehydrogenase
adrenergic alpha-1 receptor antagonists
adrenergic alpha-1 receptor antagonists
5-alpha reductase inhibitors
5-alpha reductase inhibitors
critical appraisal or critical reading

---
Nous contacter.
26/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.